Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/2/23 → 12/31/26 |
Funding
- Regeneron Pharmaceuticals, Inc. (Prot# R668-AD-22106)
Prot #R668‐AD‐22106: Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders: a Single‐Site Pilot Study
- Paller, Amy (PD/PI)
Project: Research project